Determination of Skeletal Tumor Burden on 18F-Fluoride PET/CT

被引:54
|
作者
Rohren, Eric M. [1 ]
Etchebehere, Elba C. [1 ,2 ]
Araujo, John C. [3 ]
Hobbs, Brian P. [4 ]
Swanston, Nancy M. [1 ]
Everding, Michael [1 ]
Moody, Tracy [1 ]
Macapinlac, Homer A. [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Nucl Med, Houston, TX 77030 USA
[2] Univ Estadual Campinas, UNICAMP, Div Nucl Med, Campinas, SP, Brazil
[3] Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Houston, TX 77030 USA
[4] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA
关键词
fluoride PET/CT; NaF PET/CT; prostate cancer; bone metastases; skeletal tumor burden; POSITRON-EMISSION-TOMOGRAPHY; PLANAR BONE-SCINTIGRAPHY; TOTAL LESION GLYCOLYSIS; PROSTATE-CANCER; F-18-FDG PET/CT; PROGNOSTIC VALUE; F-18-SODIUM FLUORIDE; RESPONSE ASSESSMENT; HODGKINS-LYMPHOMA; CELL;
D O I
10.2967/jnumed.115.156026
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
The purpose of this study was to define a method to assess skeletal tumor burden with F-18-labeled sodium fluoride PET/CT (F-18-fluoride PET/CT) and evaluate the reproducibility of these measurements. Methods: Ninety-eight consecutive patients (90 men; mean age +/- SD, 65.7 +/- 14.2 y) underwent 158 F-18-fluoride PET/CT scans for evaluation of skeletal metastatic disease. In order to determine the mean normal bone SUV, initially a 1-cm spheric volume of interest (V01) was placed over 5 bone sites: T12, L5, sacrum, right iliac bone, and right femur. For each patient, the mean SUVmax, for all sites was generated. Afterward, a threshold value of normal bone uptake was established. Subsequently, skeletal tumor burden was determined by generating volumetric data using a whole-body segmentation method. Any SUVmax below the normal threshold was excluded from analysis, as were VOls not related to metastatic disease. Statistics for the remaining VOls were then generated and defined as the skeletal metastatic tumor burden by 2 parameters: total lesion fluoride uptake above an SUVmax of 10 (TLF10) and fluoride tumor volume above an SUVmax of 10 (FTV10). TLF10 and FIV10 reproducibility was determined using 2 independent and experienced PET/CT interpreters analyzing a subset of 13 F-18-fluoride PET/CT scans. Results: Mean (+/- SD) normal. bone SUVmax was 6.62 +/- 1.55 for T12, 6.11 +/- 1.73 for L5, 4.59 +/- 1.74 for sacrum, 5.39 +/- 1.72 for right iliac bone, and 3.90 +/- 1.57 for right femur. The mean normal SUVmax for all 543 sites was 5.32 +/- 0.99. On the basis of these values, an SUVmax threshold of 10 was chosen to exclude normal bone from the volumetric calculations. Semiautomated measurements of TLF10 and FTV10 exhibited high interobserver reproducibility, within +/- 0.77% and +/- 3.62% of the interinterpreter average for TLF10 and FTV10, respectively. Conclusion: Determination of skeletal tumor burden with F-18-fluoride PET/CT is feasible and highly reproducible. Using an SUVmax threshold of 10 excludes nearly all normal bone activity from volumetric calculations.
引用
收藏
页码:1507 / 1512
页数:6
相关论文
共 50 条
  • [1] Determination of skeletal tumor burden on 18F-Fluoride PET/CT
    Etchebehere, Elba
    Swanston, Nancy
    Araujo, John
    Everding, Michael
    Moody, Tracy
    Macapinlac, Homer
    Rohren, Eric
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (03)
  • [2] Assessment of malignant skeletal disease:: Initial experience with 18F-fluoride PET/CT and comparison between 18F-fluoride PET and 18F-fluoride PET/CT
    Even-Sapir, E
    Metser, U
    Flusser, G
    Zuriel, L
    Kollender, Y
    Lerman, H
    Lievshitz, G
    Ron, I
    Mishani, E
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2004, 45 (02) : 272 - 278
  • [3] The Prognostic role of Skeletal Tumor Burden on 18F-Fluoride PET/CT in Metastatic Breast Cancer
    Brito, A. E.
    Mosci, C.
    Santos, A.
    Brunetto, S. Q.
    Ramos, C. D.
    Etchebehere, E.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S272 - S272
  • [4] Comparison of manual versus semiautomatic quantification of skeletal tumor burden on 18F-Fluoride PET/CT
    Brito, Ana
    Santos, Allan
    Mosci, Camila
    Oliveira, Paulo
    Souza, Thiago
    Lima, Mariana
    Ramos, Celso Dario
    Etchebehere, Elba
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2017, 58
  • [5] 18F-Fluoride PET/CT tumor burden quantification predicts survival in breast cancer
    Brito, Ana E.
    Santos, Allan
    Sasse, Andre Deeke
    Cabello, Cesar
    Oliveira, Paulo
    Mosci, Camila
    Souza, Tiago
    Amorim, Barbara
    Lima, Mariana
    Ramos, Celso D.
    Etchebehere, Elba
    [J]. ONCOTARGET, 2017, 8 (22) : 36001 - 36011
  • [6] Skeletal tumor burden on baseline 18F-Fluoride PET/CT predicts overall survival after radium-223
    Etchebehere, Elba
    Araujo, John
    Fox, Patricia
    Swanston, Nancy
    Macapinlac, Homer
    Rohren, Eric
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (03)
  • [7] SUV Normalized by Skeletal Volume on 18F-Fluoride PET/CT Studies
    Carvalho, Giovanna
    Gomes Marin, Jose Flavio
    Garcez, Alexandre Teles
    Duarte, Paulo Schiavom
    Sapienza, Marcelo Tatit
    Buchpiguel, Carlos Alberto
    [J]. CLINICAL NUCLEAR MEDICINE, 2016, 41 (07) : 529 - 533
  • [8] Skeletal tumor burden on baseline 18F-fluoride PET/CT to predict bone marrow failure after radium-223.
    Etchebehere, Elba
    Araujo, John C.
    Milton, Denai
    Fox, Patricia S.
    Swanston, Nancy
    Macapinlac, Homer A.
    Rohren, Eric
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [9] Skeletal Tumor Burden on Baseline 18F-Fluoride PET/CT Predicts Bone Marrow Failure After 223Ra Therapy
    Etchebehere, Elba C.
    Araujo, John C.
    Milton, Denai R.
    Erwin, William D.
    Wendt, Richard E., III
    Swanston, Nancy M.
    Fox, Patricia
    Macapinlac, Homer A.
    Rohren, Eric M.
    [J]. CLINICAL NUCLEAR MEDICINE, 2016, 41 (04) : 268 - 273
  • [10] Prognostic Factors in Patients Treated with 223Ra: The Role of Skeletal Tumor Burden on Baseline 18F-Fluoride PET/CT in Predicting Overall Survival
    Etchebehere, Elba C.
    Araujo, John C.
    Fox, Patricia S.
    Swanston, Nancy M.
    Macapinlac, Homer A.
    Rohren, Eric M.
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (08) : 1177 - 1184